Provider review
Willow review
Sells all four formats of both molecules and prices them as one figure.
Both molecules as a daily tablet and as a weekly injection — a needle-free route for either drug, which few here manage. A single starting figure covers all four.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Willow
From $299/mo covering all four formats, none priced separately
- Vs median
- $130/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The catalog here is unusually complete. Both molecules in both formats — a daily tablet and a weekly injection for each — which means a reader who will not inject has an actual choice of drug rather than the single needle-free option most providers offer, if they offer one at all. Free two-day shipping, FSA and HSA eligibility, unlimited access to care and a free assessment with same-day approval are all stated plainly. What the site does not do is price any of it separately. One figure is given for treatment plans generally, and everywhere else on this site the gaps between these four things are real and often large: tirzepatide usually costs more than semaglutide, and oral formats are priced apart from injectables in both directions depending on the seller. Quoting one number across all four leaves a reader unable to work out which of the four that number actually buys, or what the other three cost. Add that the figure is a starting point with no dose behind it, and the position is that the catalog is admirably clear while the pricing is not.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You will not inject and want a real choice of molecule rather than one oral option.
- You want FSA or HSA eligibility with free two-day shipping.
- You want a free assessment with the possibility of same-day approval.
Look elsewhere if
- You are comparing formats on price. One figure covers all four of them.
- You want to know if tirzepatide costs more here. Nothing published says.
- You are pricing a dose. The figure is a starting point with none behind it.
What it actually costs
Price as published
Treatment plans stated to "start at $299 per month", including the personalized GLP-1 medication · ★ it carries all four formats — semaglutide tablets and injection, tirzepatide tablets and injection — so both molecules are available needle-free as well as weekly, which few providers here manage · FSA and HSA eligible, free two-day shipping, and unlimited access to care stated · one figure covers the whole range, so nothing published says whether the daily tablets cost the same as the weekly injection or whether tirzepatide costs more than semaglutide — and on every other site here those gaps are real and often large · no dose is published behind the figure, and it is a "start at"
- Vs median
- $130/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. ★ All four formats are carried — both molecules as a daily tablet and as a weekly injection — so a needle-free route exists for either drug. One "start at" figure covers all four, so no format and no molecule is priced individually and nothing is readable per molecule before intake. No low-dose product.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Carries both molecules in both formats, so a needle-free route exists for either drug.
- FSA and HSA eligible with free two-day shipping and unlimited access to care.
- The eligibility assessment is free and offers same-day approval.
Pharmacy, labs and oversight
Willow dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Willow publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The catalog here is unusually complete. Both molecules in both formats — a daily tablet and a weekly injection for each — which means a reader who will not inject has a real choice of drug rather than the single needle-free option most providers offer if they offer one at all. Free two-day shipping, FSA and HSA eligibility and unlimited access to care are all stated plainly. What the site does not do is price any of it separately. A single figure is given for treatment plans generally, and everywhere else on this site the gaps between these four things are real: tirzepatide usually costs more than semaglutide, and oral formats are often priced apart from injectables in both directions. Quoting one number across all four leaves a reader unable to tell which of the four the figure actually buys, or what the others cost. Add that the figure is a starting point with no dose behind it, and the practical position is that the catalog is clear and the pricing is not.
The honest cons
One figure covers all four formats, so none of them is priced individually.
- The figure is a starting point with no dose published behind it.
- No compounding pharmacy is named.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Willow is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#207 of 373
Ordered with the companies that pay us first, and Willow is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- Oral semaglutide (Rybelsus)
- Microdosing tirzepatide
- The true annual cost of a plan
- Microdose & reconstitution calculator
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.